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Abstract
Purpose The survival for patients with lymphoma has im-
proved over the past decades with the introduction of novel
agents. Quality of life of these survivors is now being studied
with focus on minimising the late effects of chemotherapy and
improving psychosocial support. This study aims to determine
the prevalence of anxiety and depression of lymphoma survi-
vors and to investigate the possible association between these
disorders and quality of life.
Methods Patients with previous diagnosis of lymphoma who
remained in remission were recruited from a major hospital in
Malaysia. Quality of life of these patients was measured using
European Organisation for Research and Treatment of Cancer
Quality of Life Questionnaire (EORTC QLQ C30). Anxiety
and depression symptoms were assessed using Hospital
Anxiety and Depression scale (HADS).
Results A total of 156 patients participated in this study.
Eighteen percent (18 %) of patients had symptoms of anxiety,
and 10 % had symptoms of depression. Patients who had higher
depression scores were older, of lower education level and had
more than one comorbidity illness. Patients with anxiety were
associated with lower overall quality of life (QOL) score, lower
emotional and cognitive functioning and complained more of
fatigue and insomnia (p < 0.05). Patients who had depression
were associated with lower physical functioning and complained
more of insomnia (p < 0.05).
Conclusion It is important for the treating physicians to en-
sure follow-up of lymphoma survivors for any psychological
disorders in order early counseling and support can be provid-
ed. This may improve patients’ quality of life.
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Introduction
Lymphoid neoplasms are one of the most common haemato-
logical cancers. In the USA, 84 % of haematological cancers
are lymphoid neoplasms [1]. Non-Hodgkin lymphoma (NHL)
accounted for approximately 80% of all lymphoid neoplasms,
and Hodgkin lymphoma (HL) accounted for 8 % [2]. NHL is
the eighth most common cancer in the USA, and in Malaysia,
lymphoma is the sixth most common cancer accounting for
about 4.3 % of all cancers [3, 4]. Survival had improved sig-
nificantly for both NHL and HL in the past decades in many
countries including Asian regions [4–6]. The much improved
survival rates and curability for lymphoma in recent years are
the result of introduction of monoclonal antibody therapy in
combination of chemotherapy drugs and newer radiotherapy
technology [7–9]. In Malaysia, a recent study showed the 3-
year overall survival rate of patients with DLBCL was 80 %
[10].With improved survival, patients are now reporting more
treatment-related side effects such as cardiac dysfunction, sec-
ondary malignancies and gonadal dysfunction. There have
been some evidences to show that these may in turn compro-
mise their quality of life (QOL) [11, 12].
Majority of the studies on QOL in lymphoma survivors
were limited to the western populations [13, 14]. A systematic
review by Arden-Close et al. showed that the lymphoma sur-
vivors had a worse physical HRQOL than the normal
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